2022-12-16
Dr Mateusz Gliwinski, an employee of PolTREG S.A., was awarded the Prime Minister’s Award for Outstanding Doctoral Dissertation: “Antigen-specific regulation of the immune system in type 1 diabetes” carried out under the LEADER program, STRATEGMED NCBiR and the R&D program of PolTREG S.A. The dissertation promoters were dr Dorota Iwaszkiewicz-Grześ and prof. Piotr Trzonkowski.
2023-06-15
PolTREG is expanding its cGMP capabilities, which are currently out-sourced, with the announcement of the completion of the first stage investment in and construction of its own state-of-the art cell and gene therapy manufacturing facility
2023-05-25
Prof. Piotr Trzonkowski, CEO of PolTREG has been awarded the Wprost Health Visioner 2023 Award
